ImmunoGen Reports Recent Progress and Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Immunogen (IMGN) Tops Q2 EPS by 3c
July 31, 2020 6:41 AM EDTImmunogen (NASDAQ: IMGN) reported Q2 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $15 million versus the consensus estimate of $14.59 million.
GUIDANCE:
Immunogen sees FY2020 revenue of $60-65 million, versus the consensus of $63.1... More
